AGE-RELATED MACULAR DEGENERATION (ARMD)
Clinical trials for AGE-RELATED MACULAR DEGENERATION (ARMD) explained in plain language.
Never miss a new study
Get alerted when new AGE-RELATED MACULAR DEGENERATION (ARMD) trials appear
Sign up with your email to follow new studies for AGE-RELATED MACULAR DEGENERATION (ARMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Higher-Dose eye injection may help wet AMD patients who Didn't respond to standard treatments
Disease control CompletedThis study tests whether switching to a higher dose (8mg) of aflibercept can help people with wet age-related macular degeneration (AMD) who have not responded well to standard treatments like faricimab or the usual 2mg dose of aflibercept. Participants receive up to three inject…
Matched conditions: AGE-RELATED MACULAR DEGENERATION (ARMD)
Phase: PHASE4 • Sponsor: Kim's Eye Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Gut health hack: supplement shows promise for dry eyes
Symptom relief CompletedThis study tested whether a dietary supplement could improve dry eye symptoms by changing the bacteria in the gut. Twenty adults with dry eye disease took the supplement for 8 weeks. Researchers measured tear production and eye surface health before and after treatment. The goal …
Matched conditions: AGE-RELATED MACULAR DEGENERATION (ARMD)
Phase: NA • Sponsor: Varol TUNALI • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Eye injection burden varies by disease, study finds
Knowledge-focused CompletedThis study looked at how much of a burden patients feel from repeated anti-VEGF eye injections for three different eye diseases: wet age-related macular degeneration, retinal vein occlusion, and diabetic macular edema. Researchers surveyed 393 patients about their treatment burde…
Matched conditions: AGE-RELATED MACULAR DEGENERATION (ARMD)
Sponsor: Hospital Hietzing • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC